SET/TAF-I antibody 55201-1-AP from Proteintech Group Inc

Product Specs
ItemSET/TAF-I antibody
CompanyProteintech Group Inc
Price Pricing Info Supplier Page View Company Product Page
Catalog Number55201-1-AP
Conjugate/TagUnconjugated
IsotypeIgG
FormatPBS with 0.02% sodium azide and 50% glycerol pH 7.3
ApplicationsWB, IHC, ELISA
ReactivityHuman, Mouse
ClonalityPolyclonal
HostRabbit
Antibody Typeprimary antibodies
Quantity20ul
PurityAntigen affinity purification
ImmunogenPeptide
NCBI Full Gene NameSET nuclear proto-oncogene
NCBI Gene Aliases2PP2A, I2PP2A, IGAAD, IPP2A2, MRD58, PHAPII, TAF-I, TAF-IBETA
Research AreaApoptosis, Binding Proteins, Cell Cycle, Cytoskeleton/Scaffold Proteins, Metabolism, Neurology
ValidationKD/KO Validated
TargetSET/TAF-I

Specifications/Features

20ul available

Add to Compare List

Proteintech Group Inc

5500 Pearl Street, Suite 400

Rosemont,, Illinois 60018

United States

Phone: 1-888-478-4522

Email: proteintech@ptglab.com

Company Profile

Website: http://www.ptglab.com

(1) A protocol to investigate the effects of lncRNAs on in vivo protein-protein interactions using proximity ligation assaySTAR ProtocDecember 2, 2023Ling Zhang, Mengfan He, Peizhen Wang, Jianfeng Yu, Dawei LiPLA)",Santa Cruz,Cat# sc-133138; RRID: AB_2185628 "Rabbit anti-SET (1:1,000 for WB)",Proteintech,Cat# 55201-1-AP; RRID: AB_10837360 "Anti-mouse IgG, HRP (1:3,000)",GE Healthcare,Cat# NA931; RRID: AB_772210 "Anti-rabbit

(2) A p53/LINC00324 positive feedback loop suppresses tumor growth by counteracting SET-mediated transcriptional repressionCell reportsAugust 29, 2023Zhang L, Zhang J, Xuan X, Wu D, Yu J, Wang P, Yang X, Zhang J, Gan W, He M, et al.

(3) The Effects of Protein Phosphatase 2A Activation with Novel Tricyclic Sulfonamides on HepatoblastomaJournal of pediatric surgeryJune 1, 2023Bownes LV, Julson JR, Quinn CH, Hutchins SC, Erwin MH, Markert HR, Stewart JE, Mroczek-Musulman E, Aye J, Yoon KJ, et al.

(4) Structure-Activity Relationship Studies of Venglustat on NTMT1 InhibitionJournal of medicinal chemistryJanuary 26, 2023Deng Y, Dong G, Meng Y, Noinaj N, Huang R.proteins were used: me3-SPK (Schaner Tooley lab), RCC1 (Proteintech, #22142-1-AP), SET (Proteintech, #55201-1-AP), and horseradish peroxidase (HRP)-linked anti-rabbit IgG (cell signaling, #7074S). Protein Expression

(5) Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for NeuroblastomaCancersApril 13, 2022Bownes LV, Marayati R, Quinn CH, Beierle AM, Hutchins SC, Julson JR, Erwin MH, Stewart JE, Mroczek-Musulman E, Ohlmeyer M, et al.

(6) MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-small-cell lung cancerBMC cancerNovember 13, 2021Pan H, Pan Z, Guo F, Meng F, Zu L, Fan Y, Li Y, Li M, Du X, Zhang X, et al.1 h, the nitrocellulose membrane was hybridized with primary antibodies against anti-SET (cat. no. 55201-1-AP) from Proteintech (Rosemont, USA); anti-E-cadherin (cat. no. 14472), Vimentin (cat. no. 5741), c-Jun

(7) Selective Peptidomimetic Inhibitors of NTMT1/2: Rational Design, Synthesis, Characterization, and Crystallographic StudiesJournal of medicinal chemistrySeptember 10, 2020Mackie BD, Chen D, Dong G, Dong C, Parker H, Schaner Tooley CE, Noinaj N, Min J, Huang R.proteins were used: Me3-SPK (Schaner Tooley lab 6), RCC1 (Proteintech, #22142–1-AP), SET (Proteintech, #55201–1-AP), Lamin B1 (Proteintech, # 12987–1-AP), Anti-rabbit IgG, HRP-linked (Cell Signaling, #7074S). NTMT1

(8) Overexpression of SET oncoprotein is associated with tumor progression and poor prognosis in human gastric cancerOncology reportsSeptember 1, 2017Yuan X, Zhang T, Zheng X, Zhang Y, Feng T, Liu P, Sun Z, Qin S, Liu X, Zhang L, et al.β -actin (1:50,000 dilution; cat. no. A3854) (Sigma-Aldrich); anti‑SET (1:2,000 dilution; cat. no. 55201-1-AP), anti‑c‑Myc (1:2,000 dilution; cat. no. 10828‑1-AP) (Proteintech); anti‑MMP2 (1:2,000 dilution; cat.

(9) Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancerOncotargetJune 20, 2015Liu H, Gu Y, Wang H, Yin J, Zheng G, Zhang Z, Lu M, Wang C, He Z.

(10) SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cellCellular signallingDecember 1, 2014Liu H, Gu Y, Yin J, Zheng G, Wang C, Zhang Z, Deng M, Liu J, Jia X, He Z.

(11) Reactivating PP2A by FTY720 as a novel therapy for AML with C-KIT tyrosine kinase domain mutationJournal of cellular biochemistryApril 1, 2012Yang Y, Huang Q, Lu Y, Li X, Huang S.